BRPI0810835A2 - Formulações de hidroquinona ansamicina - Google Patents

Formulações de hidroquinona ansamicina

Info

Publication number
BRPI0810835A2
BRPI0810835A2 BRPI0810835-8A BRPI0810835A BRPI0810835A2 BR PI0810835 A2 BRPI0810835 A2 BR PI0810835A2 BR PI0810835 A BRPI0810835 A BR PI0810835A BR PI0810835 A2 BRPI0810835 A2 BR PI0810835A2
Authority
BR
Brazil
Prior art keywords
anxamycin
hydroquinone
formulations
hydroquinone formulations
anxamycin hydroquinone
Prior art date
Application number
BRPI0810835-8A
Other languages
English (en)
Inventor
James L Wright
James R Porter
Original Assignee
Infinity Discovery Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Infinity Discovery Inc filed Critical Infinity Discovery Inc
Publication of BRPI0810835A2 publication Critical patent/BRPI0810835A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
BRPI0810835-8A 2007-04-12 2008-04-11 Formulações de hidroquinona ansamicina BRPI0810835A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91133007P 2007-04-12 2007-04-12
PCT/US2008/060063 WO2008128063A1 (en) 2007-04-12 2008-04-11 Hydroquinone ansamycin formulations

Publications (1)

Publication Number Publication Date
BRPI0810835A2 true BRPI0810835A2 (pt) 2015-06-16

Family

ID=39628966

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0810835-8A BRPI0810835A2 (pt) 2007-04-12 2008-04-11 Formulações de hidroquinona ansamicina

Country Status (10)

Country Link
US (1) US20080255080A1 (pt)
EP (1) EP2134338A1 (pt)
JP (1) JP2010523710A (pt)
CN (1) CN101677991A (pt)
AU (1) AU2008240179A1 (pt)
BR (1) BRPI0810835A2 (pt)
CA (1) CA2684211A1 (pt)
IL (1) IL201283A0 (pt)
MX (1) MX2009010808A (pt)
WO (1) WO2008128063A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0418147A (pt) 2003-12-23 2007-04-17 Infinity Pharmaceuticals Inc análogos de ansamicinas contendo benzoquinona e seus métodos de uso
WO2010045442A1 (en) 2008-10-15 2010-04-22 Infinity Discovery, Inc. Ansamycin hydroquinone compositions
CN115227692A (zh) * 2022-09-05 2022-10-25 中国医学科学院基础医学研究所 Reblastatin在制备治疗慢性惊厥的药物中的用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4261989A (en) * 1979-02-19 1981-04-14 Kaken Chemical Co. Ltd. Geldanamycin derivatives and antitumor drug
US4762857A (en) * 1986-05-30 1988-08-09 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US5387584A (en) * 1993-04-07 1995-02-07 Pfizer Inc. Bicyclic ansamycins
US5932566A (en) * 1994-06-16 1999-08-03 Pfizer Inc. Ansamycin derivatives as antioncogene and anticancer agents
JP2001516329A (ja) * 1995-06-07 2001-09-25 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア ポリヌクレオチド複合体の安定化
ZA9811127B (en) * 1997-12-09 2000-07-11 Lilly Co Eli Stabilized teriparatide solutions.
CA2321480A1 (en) * 1998-02-18 1999-08-26 Laurence Anthony Seabra Treating cancer
CA2430692C (en) * 2001-03-30 2011-05-31 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Geldanamycin derivative and use of same to treat cancer
US6872715B2 (en) * 2001-08-06 2005-03-29 Kosan Biosciences, Inc. Benzoquinone ansamycins
EP1472230B1 (en) * 2002-02-08 2009-06-17 Conforma Therapeutic Corporation Ansamycins having improved pharmacological and biological properties
BRPI0311959B8 (pt) * 2002-06-21 2021-05-25 Novo Nordisk Healthcare Ag composição, métodos para preparar um polipeptídeo estável do fator vii, e para tratar uma síndrome responsiva do fator vii, e, uso do polipeptídeo do fator vii
BRPI0418147A (pt) * 2003-12-23 2007-04-17 Infinity Pharmaceuticals Inc análogos de ansamicinas contendo benzoquinona e seus métodos de uso
US20060019941A1 (en) * 2003-12-23 2006-01-26 Infinity Pharmaceuticals, Inc. Analogs of benzoquinone-containing ansamycins and methods of use thereof
US20070048323A1 (en) * 2004-02-20 2007-03-01 Rubin J P Antibody treatment of lipomatous tumors
EP1863769A4 (en) * 2005-03-11 2009-03-18 Univ Colorado HSP90 INHIBITORS, METHOD FOR THE PRODUCTION THEREOF AND THEIR APPLICATIONS
US20100279994A1 (en) * 2005-06-21 2010-11-04 Inifinity Discovery, Inc. Ansamycin Formulations and Methods of Use Thereof
AU2006320435A1 (en) * 2005-12-01 2007-06-07 Conforma Therapeutics Corporation Compositions containing ansamycin
PL2526933T3 (pl) * 2006-09-22 2015-08-31 Pharmacyclics Llc Inhibitory kinazy tyrozynowej Brutona

Also Published As

Publication number Publication date
AU2008240179A1 (en) 2008-10-23
WO2008128063A1 (en) 2008-10-23
CA2684211A1 (en) 2008-10-23
JP2010523710A (ja) 2010-07-15
EP2134338A1 (en) 2009-12-23
CN101677991A (zh) 2010-03-24
MX2009010808A (es) 2009-10-29
IL201283A0 (en) 2010-05-31
US20080255080A1 (en) 2008-10-16

Similar Documents

Publication Publication Date Title
BRPI0814188A2 (pt) Formulações
BRPI0814252A2 (pt) Formulações de anticorpo
PT2889310T (pt) Formulações de anticorpo
DK2068886T3 (da) Lipidholdige præparater
ES2527409T4 (es) Formulaciones de inhibidores de DPP IV
EP2131650A4 (en) PERFUSION REGULATION
EP2157090A4 (en) PYRAZINAMIDE COMPOUND
DE602008006301D1 (de) Koaxialnadelanordnung
BRPI0820381A2 (pt) Formulações farmacêuticas
EP2188984A4 (en) PREPARATION OF TRANSPORT FLOW PACKAGE (TS)
EP2160187A4 (en) SPIROINDALONE
DE602007007755D1 (de) Fußplatte
DK2125048T3 (da) Præparat
BRPI0812994A2 (pt) Microbiocidas
DE602008004695D1 (de) Katalysatorträgerwabe
EP2151172A4 (en) LIGHT EMITTING DEVICE
EP2182216A4 (en) COMPRESSOR WITH ONE SCREW
DE602008000912D1 (de) Schaltanlage
BRPI0809653A2 (pt) Formulações líquidas de manoproteína
FI20075310A0 (fi) Aksiaalivuoinduktiosähkökone
EP2174732A4 (en) can seamer
FI20075115A0 (fi) Tuloilmayksikkö
EP2209817A4 (en) ANTIVIRAL COMPOSITIONS
DE602007008359D1 (de) Hemdendbearbeitungsmaschine
IS8612A (is) Stöðugar statínlyfjasamsetningar

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.